Detalles de la búsqueda
1.
Development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model.
J Virol
; 88(9): 5100-8, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24574396
2.
Correction for Kim et al., development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model.
J Virol
; 89(9): 5193, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25841050
3.
The effect of respiratory viruses on immunogenicity and protection induced by a candidate universal influenza vaccine in mice.
PLoS One
; 14(4): e0215321, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30986224
4.
Development of a simple, rapid, sensitive, high-throughput luciferase reporter based microneutralization test for measurement of virus neutralizing antibodies following Respiratory Syncytial Virus vaccination and infection.
Vaccine
; 31(37): 3987-94, 2013 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23742994
5.
Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.
J Virol
; 81(1): 261-71, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17050595
Resultados
1 -
5
de 5
1
Próxima >
>>